心力衰竭99——MOXCON的故事。 - Suppr

Heart Failure 99 -- the MOXCON story.

作者信息

Coats A J

出版信息

Int J Cardiol. 1999 Oct 31;71(2):109-11. doi: 10.1016/s0167-5273(99)00120-5.

DOI:10.1016/s0167-5273(99)00120-5

PMID:10574393

Abstract

摘要

相似文献

Heart Failure 99 -- the MOXCON story.

Int J Cardiol. 1999 Oct 31;71(2):109-11. doi: 10.1016/s0167-5273(99)00120-5.

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).

Eur J Heart Fail. 2003 Oct;5(5):659-67. doi: 10.1016/s1388-9842(03)00163-6.

[A new antihypertensive drug: clonidine or Catapressan].

Acta Clin Belg. 1969;24(6):334-55. doi: 10.1080/17843286.1969.11716728.

The use of "Catapres" in the treatment of severe hypertension.

Med J Aust. 1969 Oct 4;2(14):684-7. doi: 10.5694/j.1326-5377.1969.tb107345.x.

[Olmesartan: antihypertensive therapy].

Krankenpfl J. 2005;43(7-10):254.

[Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance].

Fortschr Med. 1993 Sep 30;111(27):429-32.

Losartan-induced bronchospasm.

J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1128-30. doi: 10.1016/s0091-6749(96)80205-3.

["High dosage monotherapy"].

Krankenpfl J. 2005;43(1-3):63.

Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure.

Eur J Clin Pharmacol. 1996;50(4):265-8. doi: 10.1007/s002280050105.

[From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].

MMW Fortschr Med. 2003 Dec 4;145(49):57.

引用本文的文献

Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Pharmacol Rev. 2013 Dec 24;66(1):308-33. doi: 10.1124/pr.112.007203. Print 2014.

Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

J Mol Cell Cardiol. 2011 Oct;51(4):518-28. doi: 10.1016/j.yjmcc.2010.11.014. Epub 2010 Nov 28.

Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.

J Clin Invest. 2006 Apr;116(4):1005-15. doi: 10.1172/JCI22811.

[Strategies for perioperative sympatho-modulation].

Anaesthesist. 2005 Apr;54(4):303-18. doi: 10.1007/s00101-005-0826-1.

Heart failure in 10 years time: focus on pharmacological treatment.

Heart. 2002 Oct;88 Suppl 2(Suppl 2):ii40-6. doi: 10.1136/heart.88.suppl_2.ii40.

The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.

Curr Control Trials Cardiovasc Med. 2001;2(1):20-23. doi: 10.1186/cvm-2-1-020.

Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents.

Curr Cardiol Rep. 2001 May;3(3):224-31. doi: 10.1007/s11886-001-0027-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Heart Failure 99 -- the MOXCON story.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献